Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 224

1.

Age- and disease-related cerebral white matter changes in patients with Parkinson's disease.

de Schipper LJ, Hafkemeijer A, Bouts MJRJ, van der Grond J, Marinus J, Henselmans JML, van Hilten JJ.

Neurobiol Aging. 2019 May 13;80:203-209. doi: 10.1016/j.neurobiolaging.2019.05.004. [Epub ahead of print]

PMID:
31207552
2.

Peripheral mitochondrial function correlates with clinical severity in idiopathic Parkinson's disease.

Milanese C, Payán-Gómez C, Galvani M, Molano González N, Tresini M, Nait Abdellah S, van Roon-Mom WMC, Figini S, Marinus J, van Hilten JJ, Mastroberardino PG.

Mov Disord. 2019 May 28. doi: 10.1002/mds.27723. [Epub ahead of print]

PMID:
31136028
3.

Intraoperative test stimulation of the subthalamic nucleus aids postoperative programming of chronic stimulation settings in Parkinson's disease.

Geraedts VJ, van Ham RAP, Marinus J, van Hilten JJ, Mosch A, Hoffmann CFE, van der Gaag NA, Contarino MF.

Parkinsonism Relat Disord. 2019 May 11. pii: S1353-8020(19)30238-X. doi: 10.1016/j.parkreldis.2019.05.017. [Epub ahead of print]

PMID:
31105015
4.

Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson's disease heritability.

Reynolds RH, Botía J, Nalls MA; International Parkinson’s Disease Genomics Consortium (IPDGC); System Genomics of Parkinson’s Disease (SGPD), Hardy J, Gagliano Taliun SA, Ryten M.

NPJ Parkinsons Dis. 2019 Apr 17;5:6. doi: 10.1038/s41531-019-0076-6. eCollection 2019.

5.

Parkinson's disease age at onset genome-wide association study: Defining heritability, genetic loci, and α-synuclein mechanisms.

Blauwendraat C, Heilbron K, Vallerga CL, Bandres-Ciga S, von Coelln R, Pihlstrøm L, Simón-Sánchez J, Schulte C, Sharma M, Krohn L, Siitonen A, Iwaki H, Leonard H, Noyce AJ, Tan M, Gibbs JR, Hernandez DG, Scholz SW, Jankovic J, Shulman LM, Lesage S, Corvol JC, Brice A, van Hilten JJ, Marinus J; 23andMe Research Team, Eerola-Rautio J, Tienari P, Majamaa K, Toft M, Grosset DG, Gasser T, Heutink P, Shulman JM, Wood N, Hardy J, Morris HR, Hinds DA, Gratten J, Visscher PM, Gan-Or Z, Nalls MA, Singleton AB; International Parkinson's Disease Genomics Consortium (IPDGC).

Mov Disord. 2019 Jun;34(6):866-875. doi: 10.1002/mds.27659. Epub 2019 Apr 7.

PMID:
30957308
6.

Walking adaptability for targeted fall-risk assessments.

Geerse DJ, Roerdink M, Marinus J, van Hilten JJ.

Gait Posture. 2019 May;70:203-210. doi: 10.1016/j.gaitpost.2019.02.013. Epub 2019 Feb 20.

PMID:
30901621
7.

Sex matters in complex regional pain syndrome.

van Velzen GAJ, Huygen FJPM, van Kleef M, van Eijs FV, Marinus J, van Hilten JJ.

Eur J Pain. 2019 Feb 8. doi: 10.1002/ejp.1375. [Epub ahead of print]

PMID:
30735277
8.

The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease.

Bandres-Ciga S, Saez-Atienzar S, Bonet-Ponce L, Billingsley K, Vitale D, Blauwendraat C, Gibbs JR, Pihlstrøm L, Gan-Or Z; International Parkinson's Disease Genomics Consortium (IPDGC), Cookson MR, Nalls MA, Singleton AB.

Mov Disord. 2019 Apr;34(4):460-468. doi: 10.1002/mds.27614. Epub 2019 Jan 24.

PMID:
30675927
9.

Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease.

Verschuur CVM, Suwijn SR, Boel JA, Post B, Bloem BR, van Hilten JJ, van Laar T, Tissingh G, Munts AG, Deuschl G, Lang AE, Dijkgraaf MGW, de Haan RJ, de Bie RMA; LEAP Study Group.

N Engl J Med. 2019 Jan 24;380(4):315-324. doi: 10.1056/NEJMoa1809983.

PMID:
30673543
10.

Studying reproducibility of data-driven Parkinson's disease subtypes.

van Rooden SM, Verbaan D, Jeukens-Visser M, van Hilten JJ.

Parkinsonism Relat Disord. 2019 Jan 4. pii: S1353-8020(18)30561-3. doi: 10.1016/j.parkreldis.2018.12.027. [Epub ahead of print] No abstract available.

PMID:
30638819
11.

Assessing Walking Adaptability in Parkinson's Disease: "The Interactive Walkway".

Geerse DJ, Roerdink M, Marinus J, van Hilten JJ.

Front Neurol. 2018 Dec 12;9:1096. doi: 10.3389/fneur.2018.01096. eCollection 2018.

12.

LRP10 in α-synucleinopathies.

Kia DA, Sabir MS, Ahmed S, Trinh J, Bandres-Ciga S; International Parkinson's Disease Genomics Consortium.

Lancet Neurol. 2018 Dec;17(12):1032. doi: 10.1016/S1474-4422(18)30401-0. Epub 2018 Nov 13. No abstract available.

PMID:
30507383
13.

Optical Hand Tracking: A Novel Technique for the Assessment of Bradykinesia in Parkinson's Disease.

Bank PJM, Marinus J, Meskers CGM, de Groot JH, van Hilten JJ.

Mov Disord Clin Pract. 2017 Sep 13;4(6):875-883. doi: 10.1002/mdc3.12536. eCollection 2017 Nov-Dec.

14.

Clinical correlates of quantitative EEG in Parkinson disease: A systematic review.

Geraedts VJ, Boon LI, Marinus J, Gouw AA, van Hilten JJ, Stam CJ, Tannemaat MR, Contarino MF.

Neurology. 2018 Nov 6;91(19):871-883. doi: 10.1212/WNL.0000000000006473. Epub 2018 Oct 5. Review.

PMID:
30291182
15.

Cognitive-motor interference during goal-directed upper-limb movements.

Bank PJM, Marinus J, van Tol RM, Groeneveld IF, Goossens PH, de Groot JH, van Hilten JJ, Meskers CGM.

Eur J Neurosci. 2018 Nov;48(10):3146-3158. doi: 10.1111/ejn.14168. Epub 2018 Oct 20.

16.

Altered Whole-Brain and Network-Based Functional Connectivity in Parkinson's Disease.

de Schipper LJ, Hafkemeijer A, van der Grond J, Marinus J, Henselmans JML, van Hilten JJ.

Front Neurol. 2018 Jun 6;9:419. doi: 10.3389/fneur.2018.00419. eCollection 2018.

17.

Quantitative EEG reflects non-dopaminergic disease severity in Parkinson's disease.

Geraedts VJ, Marinus J, Gouw AA, Mosch A, Stam CJ, van Hilten JJ, Contarino MF, Tannemaat MR.

Clin Neurophysiol. 2018 Aug;129(8):1748-1755. doi: 10.1016/j.clinph.2018.04.752. Epub 2018 May 29.

PMID:
29887401
18.

Oral Health of Parkinson's Disease Patients: A Case-Control Study.

van Stiphout MAE, Marinus J, van Hilten JJ, Lobbezoo F, de Baat C.

Parkinsons Dis. 2018 May 8;2018:9315285. doi: 10.1155/2018/9315285. eCollection 2018.

19.

Risk factors for non-motor symptoms in Parkinson's disease.

Marinus J, Zhu K, Marras C, Aarsland D, van Hilten JJ.

Lancet Neurol. 2018 Jun;17(6):559-568. doi: 10.1016/S1474-4422(18)30127-3. Epub 2018 Apr 23. Review.

PMID:
29699914
20.

Does deep brain stimulation of the subthalamic nucleus prolong survival in Parkinson's Disease?

Contarino MF, Marinus J, van Hilten JJ.

Mov Disord. 2018 Jul;33(6):947-949. doi: 10.1002/mds.27384. Epub 2018 Apr 11. No abstract available.

PMID:
29644757

Supplemental Content

Loading ...
Support Center